May. 9 at 11:08 AM
$KZIA One single limit buy of 41,000 shares was made close to the end of the days trading on Friday. It cleared multiple sell layers on the ask side. Somewhat lazy and arrogant - as more patience could have secured the shares a little cheaper. But it is very apparent here that the share price is going much higher and quickly. Buyer can easily get away with a sloppy approach. Look for
$20 this week and
$30 SP, by the end of the month. Celcuity purchased their PI3K mTOR drug for upfront 5 million in 2021 and now that company has a float of over
$6 billion. Kazia float is just
$155M. All in just five years, but very much to Kazia's advantage is what has Celcuity has achieved - it has opened a pathway for investors to see the massive upside for Kazia and again outstanding clinical results. What lies ahead is only now starting to become clear. A once in 20-year opportunity seemingly.
